Tag

GLP-1

Glucagon-like peptide-1 receptor pathway.

Featured

Editor's picks.

A laboratory overview of RT3 (LY3437943) — a triple agonist research peptide acting on the GLP-1, GIP and glucagon receptors.

Side-by-side comparison of RT3 and Tirz across receptor profile, research context and analytical considerations.

All content

How RT3 and Sema differ in receptor activity, compound class and laboratory research framing.

Comparisons

Triple vs dual incretin agonist — receptor profile and research framing.

Triple agonist vs single GLP-1 — class, mechanism and lab context.

Selective GLP-1 agonist vs dual GIP/GLP-1 agonist — receptor pharmacology and evidence comparison.

FAQ

Is RT3 approved for human use?

No. RT3 is supplied strictly for laboratory research and is not approved for human or veterinary administration.

What receptors does RT3 act on?

In published research it has been characterised as a triple agonist acting on the GLP-1, GIP and glucagon receptors.

How should RT3 be stored?

Lyophilised vials are stored at 2–8°C, protected from light. Once reconstituted with bacteriostatic water, store refrigerated and use within 30 days.

Which is the newer research compound?

RT3 is the more recently characterised compound in the academic literature, while Tirz is the more established reference.